BioSpace News Archive

- Reports First-Quarter Diluted EPS of $1.99 on a GAAP Basis; Adjusted Diluted EPS of $2.95 - Delivers First-Quarter Net Revenues of $13.010 Billion on a GAAP Basis, an Increase of 51.0 Percent on a Reported Basis; Adjusted Net Revenues Were $12.935 Billion

Thermo Fisher Scientific, the world leader in serving science, today launched the Thermo Scientific E-CFEG, the company’s new cold field emission gun and a value-added component for the Thermo Scientific Krios Cryo-TEM.

AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its annual financial results for the year ended December 31, 2020.

Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced that it will report first quarter 2021 financial results on Thursday, May 6, 2021, after the market close.

BeyondSpring Inc., a global biopharmaceutical company focused on the development of innovative cancer therapies, announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission on April 30, 2021.